Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Multiple Myeloma, Date of authorisation: 26/03/2021,...
The most common side effects with Nexpovio used together with bortezomib and dexamethasone (which may affect more than 3 in 10 people) are thrombocytopenia (low blood platelet counts), nausea (feeling sick), tiredness, anaemia (low red blood cell counts), …